PPI Use May Affect Cognition in Individuals Previously Treated for Breast Cancer
January 20, 2020
Proton pump inhibitors (PPIs) may be linked to concentration and memory problems in individuals with a history of breast cancer.
Recent Content
Pharmacy Trends in 2020 and Beyond: Preparing for a New Decade
January 20, 2020
As we head into a new year, Drug Topics® is exploring some of the latest pharmacy trends and how they will shape the industry in the next decade.
Sunosi for Excessive Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
January 20, 2020
Solriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.
FDA OKs Cardiovascular Risk Reduction Indication for Semaglutide
January 17, 2020
The FDA has approved semaglutide (Ozempic, Novo Nordisk) for the reduction of major adverse cardiovascular (CV) events in patients with type 2 diabetes and established CV disease.
What Pharmacists Are Saying About Stress
January 17, 2020
Let’s take a look at some of the most common issues pharmacists are facing, as seen recently on Facebook.
What Pharmacists Need to Know About Psoriasis Medications
January 17, 2020
Pharmacists can play an integral role in managing patients with psoriasis through medication therapies and lifestyle modifications.
What’s the Cost of Herpes Zoster?
January 17, 2020
The impact of herpes zoster can be measured in a number of different ways.
Pharmacist Groups Laud Supreme Court PBM Case Hearing
January 16, 2020
The NACDS and NCPA praised the United States Supreme Court's decision to hear a case involving states’ regulation of pharmacy benefit managers.
Nektar Withdraws NDA for Opioid Therapy After FDA Committee Vote
January 16, 2020
The FDA Committees voted against recommending approval of Nektar Therapeutics' oxycodegol.
FDA Grants Fast Track Designation to Flu Vaccine for Older Adults
January 16, 2020
Novavax’s recombinant quadrivalent flu vaccine candidate (NanoFlu) is being evaluated in an ongoing phase 3 clinical study for use in older adults.
